Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Siliankang in Type 2 Diabetes and Constipation
NCT04982380Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2021
- Primary completion
- Jul 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of Bifidobacterium tetravaccine in constipation, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
Bifidobacterium tetravaccine
03
Conditions
constipation
Beyond the preview
Go deeper on NCT04982380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04982380.